Shelly Bilbro
Nurse Practitioner · Brandon, MSNPI 1417561614
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,839 of the $7,872 with a category attached, or 86.9%. 26 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 27.4% of the total. Reporting peaked in 2024 at $3,609 and has fallen 55.4% since, to $1,608 in 2025. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 294 payments — averaging $26.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Sanofi$892
- GSK$684
- Jazz Pharmaceuticals Inc.$682
- Boehringer Ingelheim$661
- AstraZeneca$615
- plus $2K from 20 others
What the payments were for
- Travel & lodging$92612%
- Food & beverage$6,83987%
- Education$1071%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 26 | $2,155 |
| Sanofi | 35 | $892 |
| GSK | 56 | $684 |
| Jazz Pharmaceuticals Inc. | 27 | $682 |
| Boehringer Ingelheim | 36 | $661 |
| AstraZeneca | 16 | $615 |
| Regeneron Healthcare Solutions, Inc. | 16 | $463 |
| Mallinckrodt Hospital Products Inc. | 9 | $245 |
| Avadel CNS Pharmaceuticals, LLC | 10 | $197 |
| Actelion Pharmaceuticals US, Inc. | 8 | $192 |
| Mylan Specialty L.p. | 7 | $149 |
| ANI Pharmaceuticals, Inc. | 6 | $142 |
| Baxter Healthcare | 7 | $138 |
| Verona Pharma, Inc. | 7 | $111 |
| Amgen | 6 | $100 |
| Axsome Therapeutics, Inc. | 3 | $87 |
| Harmony Biosciences LLC | 4 | $76 |
| United Therapeutics Corporation | 3 | $61 |
| Insmed, Inc. | 3 | $50 |
| Bayer | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Lilly USA, LLC | 1 | $23 |
| Grifols USA, LLC | 1 | $20 |
| Philips North America LLC | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $15 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,872 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 173 | $139,352 |
| Breo ElliptaFluticasone/Vilanterol | 45 | $22,770 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 21 | $16,541 |
| Spiriva RespimatTiotropium Bromide | 20 | $15,102 |
| Spiriva HandihalerTiotropium Bromide | 11 | $12,826 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $12,506 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 28 | $10,796 |
| EliquisApixaban | 21 | $10,183 |
| SymbicortBudesonide/Formoterol Fumarate | 40 | $9,223 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 176 | $6,340 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 18 | $4,464 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $2,783 |
| Wixela InhubFluticasone Propion/Salmeterol | 15 | $1,755 |
| Montelukast Sodium | 115 | $769 |
| Zolpidem Tartrate | 72 | $378 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $684 | $178,663239 claims |
| AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Symbicort | $615 | $32,52490 claims |
| Boehringer IngelheimSpiriva Respimat | $661 | $15,10220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Brandon
- Heather KurigerBrandon$11K
- Erin BassBrandon$9K
- Cara RobbBrandon$6K
- Christina TreppendahlRidgeland$125K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Sara KlausFlowood$48K
- Micaela PerkinsOxford$32K
- Michelle TharpJackson$28K
- Kaylon LewisHattiesburg$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.